Login / Signup

Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.

Danila SeidelMichaela SimonRosanne SpruteMatthias LubnowKatja EvertClaudius SpeerJessica SeeßleElham KhatamzasUta MerleChristopher BehrensIgor Wolfgang BlauPhilipp EnghardChristian S HaasJoerg SteinmannOliver KurzaiOliver Andreas Cornely
Published in: Mycoses (2021)
COVID-19-associated mucormycosis is rare in Germany, mostly reported in patients with comorbidities and impaired immune system and severe COVID-19 treated in the ICU with high mortality compared to mainly rhino-orbito-cerebral CAM in patients with mild COVID-19 in India. Risk for CAM is higher in hospitalised COVID-19 patients than in other patients.
Keyphrases